Literature DB >> 16979605

IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-gamma-deficient mice in a Th2-biased response.

X Z Shang1, K Y Ma, J Radewonuk, J Li, X Y Song, D E Griswold, E Emmell, L Li.   

Abstract

IgE plays a critical role in the pathogenesis of allergy and asthma. Therefore, suppression of IgE production would provide therapeutic benefits to patients suffering from these diseases. We have reported that the production of IgE is regulated differently in the spleen vs. the draining lymph nodes (LN). IgE isotype switch and IgE producing B cell expansion occur in the draining LN after antigen (Ag) immunization, but do not happen in the spleen. In addition, a population of pre-existing IgE+ cells is observed in the spleen of normal or sham immunized mice, but is not present in the draining LN. To further understand the regulation of IgE production in different lymphoid organs, and the potential inhibitory factors of IgE isotype switch in the spleen, the involvement of IL-21 and IFN-gamma in regulating IgE production was investigated by using the IL-21 and the IFN-gamma deficient mice. We found that in the absence of IL-21 IgE isotype switch and IgE+ cell clonal expansion were dramatically enhanced in the spleen and IgE isotype switch was partially increased in the draining LN. In addition, IgE production of the pre-existing CD19-CD5+B220(low) IgE+ cells in the spleen was also increased in the absence of IL-21 under physiological conditions. In contrast, using the IFN-gamma deficient mice, we did not observe a negative impact of IFN-gamma on either IgE isotype switch or IgE production. Our data suggest that IL-21 appears to be a critical cytokine to keep low IgE levels under physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979605     DOI: 10.1016/j.cellimm.2006.07.011

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  20 in total

1.  SOCS3 deletion in B cells alters cytokine responses and germinal center output.

Authors:  Sarah A Jones; Christine A White; Lorraine Robb; Warren S Alexander; David M Tarlinton
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

Review 2.  Regulation of effector and memory T-cell functions by type I interferon.

Authors:  Jonathan P Huber; J David Farrar
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

Review 3.  The role of the T follicular helper cells in allergic disease.

Authors:  D M Kemeny
Journal:  Cell Mol Immunol       Date:  2012-08-20       Impact factor: 11.530

4.  A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3.

Authors:  Scott M Steward-Tharp; Arian Laurence; Yuka Kanno; Alex Kotlyar; Alejandro V Villarino; Giuseppe Sciume; Stefan Kuchen; Wolfgang Resch; Elizabeth A Wohlfert; Kan Jiang; Kiyoshi Hirahara; Golnaz Vahedi; Hong-Wei Sun; Lionel Feigenbaum; Joshua D Milner; Steven M Holland; Rafael Casellas; Fiona Powrie; John J O'Shea
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

5.  IL-21 does not involve in OVA-induced airway remodeling and chronic airway inflammation.

Authors:  Huilong Chen; Sheng Cheng; Aili Wang; Hansvin Bunjhoo; Yong Cao; Jungang Xie; Congyi Wang; Yongjian Xu; Weining Xiong
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  An Update on Lymphocyte Subtypes in Asthma and Airway Disease.

Authors:  Daniel M Moldaver; Mark Larché; Christopher D Rudulier
Journal:  Chest       Date:  2016-11-03       Impact factor: 9.410

7.  Cutting edge: histamine is required for IL-4-driven eosinophilic allergic responses.

Authors:  Julie A Swartzendruber; Adam J Byrne; Paul J Bryce
Journal:  J Immunol       Date:  2011-12-09       Impact factor: 5.422

Review 8.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

9.  HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.

Authors:  Douglas Conrad; Angela Wang; Raymond Pieters; Ferdinando Nicoletti; Katia Mangano; Anna M van Heeckeren; Steven K White; James M Frincke; Christopher L Reading; Dwight Stickney; Dominick L Auci
Journal:  J Inflamm (Lond)       Date:  2010-10-30       Impact factor: 4.981

10.  Activation of invariant natural killer T cells in regional lymph nodes as new antigen-specific immunotherapy via induction of interleukin-21 and interferon-γ.

Authors:  T Sakurai; A Inamine; T Iinuma; U Funakoshi; S Yonekura; D Sakurai; T Hanazawa; T Nakayama; Y Ishii; Y Okamoto
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.